NCT07336134Recruiting
PopSci CHW4CervixHealth
Uptake of HPV Self-sampling in Underserved Minority Women Using a Community Health Worker Model: Comparison of Evalyn Brush and Copan Floqswab
Source: ClinicalTrials.gov · Last updated 11 Aug 2026
Brief summary (registry, in English)
Phase I: Validating self-collection kit by comparing their results with clinical Pap smear results in a cohort of 20 patients. Phase II: Evaluate the feasibility and acceptability of the CHW4CervicalHealth: Use of a self-collection kit to improve cervical health screening intervention aimed to promote HPV self-collection uptake among screening-eligible and under-screened ethnic minority women in the community.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 7 Nov 2025
- Start date
- 22 Oct 2025
- Primary completion date
- 1 Oct 2026
- Lead sponsor
- Thomas Jefferson University
- Diseases
- Cervical cancer
- NCT number
- NCT07336134
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 22 Oct 2025 to the primary completion date, 1 Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous participation in an HPV self-collection study within the past 12 months
Other illness
- Presence of visible vaginal or cervical infection or symptoms suggestive of a current genital tract infection
- Have a history of hysterectomy, cervical cancer
- Self-report participation in a cervical cancer screening or other prevention study
Other
- Phase I:
- Current pregnancy (self-reported or confirmed)
- Inability to comply with study procedures or follow instructions (e.g., due to language barriers or cognitive impairments)
- Phase II:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Pregnant (self-reported)
- Inability to provide informed consent
Who the study is looking for
- Phase I:
- Women aged 25-65 years
- Scheduled for a Pap smear test appointment at Jefferson OBGYN Center City location
- Willing and able to provide informed consent for participation in the study
- Agree to perform an HPV self-collection collection procedure during the same visit
- Have not undergone a hysterectomy (intact cervix required)
- Phase II:
- This intervention targets under-screened minority individuals who must meet all the following inclusion criteria to be eligible to participate in the study:
- Women aged 25-65 years
- Who has not had a Pap smear in the past three to five years based on age of prior screening and type of screening. If under the age of 30, in the past 3 years and if over the age of 30, in the past 5 years. Participant will self-report normal pap smear and date.
- Self-identify as Hispanic, Black/African or Black Caribbean, Chinese, Korean, or Vietnamese
- Competent to give consent and provide signed and dated informed consent form in their preferred language.
Age in the registry: 25 years to 65 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Thomas Jefferson University Coordinator of this site? Confirm its status | Philadelphia | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.